Literature DB >> 18494725

Surgical treatment of central retinal vein occlusion.

Nilufer Berker1, Cosar Batman.   

Abstract

The treatment of central retinal vein occlusion (CRVO) is still a subject of debate. Medical therapy efforts, as well as retinal laser photocoagulation, have mostly dealt with management of the sequelae of CRVO, and have shown limited success in improving visual acuity. The unsatisfactory results of such therapeutic efforts led to the development of new treatment strategies focused on the surgical treatment of the occluded retinal vein. The purpose of this review is to summarize the outcomes of commonly reported surgical treatment strategies and to review different opinions on the various surgical approaches to the treatment of CRVO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494725     DOI: 10.1111/j.1755-3768.2007.01144.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  9 in total

1.  Retinal vessel cannulation with an image-guided handheld robot.

Authors:  Brian C Becker; Sandrine Voros; Louis A Lobes; James T Handa; Gregory D Hager; Cameron N Riviere
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

2.  Radial optic neurotomy in treating central retinal vein occlusion: a Meta-analysis.

Authors:  Zhen-Na Chen; Yan Shao; Xiao-Rong Li
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

3.  Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion.

Authors:  Yuan-Zhi Yuan; Fei Yuan; Qin-Yue Xu; Jia Yu; Lei Li; Ju-Li Zhang
Journal:  Chin J Integr Med       Date:  2011-04-21       Impact factor: 1.978

4.  Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.

Authors:  Thomas Ach; Alexandra E Hoeh; Karen B Schaal; Alexander F Scheuerle; Stefan Dithmar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-09       Impact factor: 3.117

5.  Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.

Authors:  Alexandra E Hoeh; Thomas Ach; Karen B Schaal; Alexander F Scheuerle; Stefan Dithmar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-26       Impact factor: 3.117

6.  Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion.

Authors:  Mei-Zi Wang; Kang Feng; Yao Lu; Fang Qian; Xin-Rong Lu; Si-Wen Zang; Lin Zhao
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

7.  Towards Vision-Based Control of a Handheld Micromanipulator for Retinal Cannulation in an Eyeball Phantom.

Authors:  Brian C Becker; Sungwook Yang; Robert A Maclachlan; Cameron N Riviere
Journal:  Proc IEEE RAS EMBS Int Conf Biomed Robot Biomechatron       Date:  2012-12-31

Review 8.  Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion.

Authors:  Steven E Bradshaw; Smeet Gala; Merena Nanavaty; Anshul Shah; Mkaya Mwamburi; Panos Kefalas
Journal:  BMC Ophthalmol       Date:  2016-07-11       Impact factor: 2.209

9.  Release of experimental retinal vein occlusions by direct intraluminal injection of ocriplasmin.

Authors:  Marc D de Smet; Jean Marie Stassen; Thijs C M Meenink; Tom Janssens; Valérie Vanheukelom; Gerrit J L Naus; Maarten J Beelen; Bart Jonckx
Journal:  Br J Ophthalmol       Date:  2016-09-28       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.